echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Eur Radiol: For predicting the survival of HCC patients, imaging performance may be more important

    Eur Radiol: For predicting the survival of HCC patients, imaging performance may be more important

    • Last Update: 2021-04-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world and the second leading cause of cancer-related deaths in the world.


    Manage blood vessels

    Recently, a study published in the journal European Radiology evaluated the relationship between tumor ADC values ​​and edge conditions and overall survival (OS) and transplant-free survival (TFS) of HCC patients, and evaluated the pairing of these two parameters including BCLC and The added value of the established clinical staging system including CLIP.


    This IRB-approved retrospective study collected clinical, laboratory and imaging data of 304 HCC patients.


    At baseline, patients with low ADC values ​​and clear edges (good imaging performance) have longer survival times than patients with high ADC values ​​and unclear edges (poor imaging performance) (median OS was 43 months, respectively) And 7 months) (p <0.


    Figure 1 Overall survival curve of ADC value and tumor margin (a), BCLC (b) and CLIP (c)

    Figure 1 Overall survival curve of ADC value and tumor margin (a), BCLC (b) and CLIP (c)

    Figure 2 integrates the good and poor imaging findings (tumor ADC value and edge conditions) into the BCLC (a) and CLIP (b) stages, and divides each stage into 3 subgroups with significant differences in median OS.


    Figure 2 integrates the good and poor imaging findings (tumor ADC value and edge conditions) into the BCLC (a) and CLIP (b) stages, and divides each stage into 3 subgroups with significant differences in median OS.


    Figure 3 The overall survival curve of BCLC and CLIP integrated imaging findings (tumor ADC value and edge conditions).


    Figure 3 The overall survival curve of BCLC and CLIP integrated imaging findings (tumor ADC value and edge conditions).


    Original source:

    Original source:

    Mounes Aliyari Ghasabeh, Mohammadreza Shaghaghi, Ankur Pandey, et al.


    DOI: org/10.


    org/10.
    1007/s00330-020-07251-4">10.
    1007/s00330-020-07251-4 Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.